Novel Insights Into the NLRP3 Inflammasome in Atherosclerosis

Cited by papers we hold 5

• Novel role for caspase 1 inhibitor VX765 in suppressing NLRP3 inflammasome assembly and atherosclerosis via promoting mitophagy and efferocytosis · 2022
  No notice
• Inflammation and atherosclerosis: signaling pathways and therapeutic intervention · 2022
  No notice
• Neuroprotective Effect of SGLT2 Inhibitors · 2021
  No notice
• Dysfunctional Vascular Endothelium as a Driver of Atherosclerosis: Emerging Insights Into Pathogenesis and Treatment · 2021
  No notice
• Neutrophil Extracellular Traps and Cardiovascular Diseases: An Update · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.